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KaplaneMeier curves and the Log-rank test.
Results: There is increased tumour epithelial cytoplasmic staining for
NR4A2, and an altered nuclear-cytoplasmic ratio with more cytoplasmic
NR4A2 in tumour compared to matched normal tissue (p ¼ 0.001). High
tumour cytoplasmic NR4A2 is associated with a signiﬁcantly worse overall
and disease speciﬁc survival in colorectal cancer. (5-year DSS 64% high
cytoplasmic NR4A2 versus 80% low cytoplasmic NR4A2, log-rank test
p¼0.049, 5-year OS p¼0.003)
Conclusions: There is marked cytoplasmic mislocalisation of NR4A2 in
colon cancer. High tumour cytoplasmic NR4A2 is associated with an
adverse prognosis.
0921: LOCALISED INHIBITION OF MICRORNA-15 AND -16 RESULTS IN AN
IMPROVED ANGIOGENIC RECOVERY FOLLOWING LIMB ISCHAEMIA
Saran Shantikumar*, Lynsey Howard, Micol Marchetti, Marco Meloni,
Costanza Emanueli. Bristol Heart Institute, Bristol, UK.
Introduction: MicroRNAs (miRNA;miR) are small non-coding RNAswhich
negatively regulatemRNA translation. miR-15&miR-16 are upregulated in
response to myocardial ischaemia, whilst inhibition protects against car-
diac ischaemic injury in a mouse model. We investigated the effect of
adenovirus-mediated local miR-15/16 inhibition in a mouse model of
hindlimb ischaemia.
Method: We generated an adenovirus capable of overexpressing a miRNA
inhibitor (Ad.Decoy-15/16), containing multiple, tandem complementary
binding sites for miR-15 and miR-16, and thus allowing speciﬁc and efﬁ-
cient depression of miR-15/16 expression. Unilateral hindlimb ischaemia
was surgically induced in anaesthetised CD1 mice (n¼12 per group) and
Ad.Decoy-15/16 or an Ad.Null control (10^9 virus particles) were delivered
to the ipsilateral adductor muscle.
Results: Blood ﬂow to the ischaemic limb was signiﬁcantly improved by
Ad.Decoy-15/16 at 7 (p<0.04), 14 (p<0.01) and 21 (p<0.03) days post-
surgery, with an average increase of ~50% compared to control mice.
Subsequent histopathological analyses at day 21 demonstrated an increase
in both capillary density (by ~30%, p<0.041) and arteriolar density (by
~40%, p<0.03) in the ischaemic adductor muscles of Ad.Decoy-15/16-
treated mice compared with control.
Conclusions: These data indicate a pro-angiogenic effect of localised
miR-15/16 inhibition in the setting of peripheral limb ischaemia in
mice.
0942: THE ROLE OF MICRORNA-30C-2* AS AN ANTIANGIOGENIC MEDI-
ATOR
Saran Shantikumar*, Andrea Caporali, Micol Marchetti, Marco Meloni,
Lynsey Howard, Costanza Emanueli. Bristol Heart Institute, Bristol, UK.
Introduction: MicroRNAs (miRs) negatively regulate the expression of
targeted mRNAs. Here, we aim to elucidate the contribution of miR-30c2*
in endothelial cell (EC) dysfunction in diabetes.
Methods: miR30c2* functional studies were performed in human
umbilical vein endothelial cells (HUVECs) under conditions of high
glucose (HG, mimics diabetes) and low growth factors (LGF, mimics
ischaemia). Expressional analyses were performed in mice, with and
without diabetes, using whole limb muscle and the ECs derived from
these tissues.
Results: MicroRNA-30c-2* expression was upregulated under LGF, HG and
a LGF/HG combination (p<0.01). In addition, miR-30c-2* was three-fold
upregulated in muscular ECs of diabetic mice (p<0.01). miR-30c-2* over-
expression induced HUVEC apoptosis and impaired angiogenesis.
Conversely, miR-30c-2* inhibition prevented LGF- and LGF/HG-induced
apoptosis and impaired angiogenesis.
The cell cycle regulator minichromosome maintenance complex compo-
nent 7 (MCM7) is a putative miR-30c-2* target. MCM-7 mRNA levels were
decreased in p75NTR-HUVECs (p<0.05 vs. Null) and in HUVECs cultured in
HG/LGF (p<0.05). miR-30c-2* overexpression reduced MCM7 mRNA
(p<0.01).
Conclusions: In conclusion, the p75NTR-induced miRNA miR-30c-2* re-
presses EC survival and angiogenesis, and may prove to be a novel thera-
peutic target for diabetes-induced endothelial damage in limbs.0967: CHARACTERIZATION OF INITIATING PHYSIOLOGICAL EVENTS OF
MAMMARY GLAND INVOLUTION: EVIDENCE FOR CATHEPSIN B
INVOLVEMENT
Vlad Paraoan 1,*, Christine Watson 2. 1 Trinity College, Cambridge University,
Cambridgeshire, UK; 2Department of Pathology, Cambridge University,
Cambridgeshire, UK.
Introduction: The mechanism of one of the most extensive physiological
cell death in mammals, postlactational regression (involution) of the
mammary gland, was recently characterized as a non-classical, lysosomal-
mediated and caspase-independent pathway of cell death. Expression of
cysteine proteinases cathepsins B and L was shown to be highly increased
via Stat3 pathway during this process. The present study aimed to inves-
tigate the intracellular trafﬁcking and potential involvement of cathepsins
B and L in the physiological events leading to involution mediated by
lysosomal membrane permeability.
Methods: Fluorescent immunohistochemical staining of mammary gland
sections fromwild type and Stat3 KOmice was performed for cathepsins B,
L and aelactalbumin, alongside co-staining of the lysosome associated
membrane protein-2 (LAMP2). Intracellular (co-) localizationwas analysed
by deconvolution ﬂuorescence microscopy.
Results: Both cathepsins B and L, but not aelactalbumin, showed strong
co-localization with LAMP2, indicating lysosomal translocation, in the
presence of functional wild-type Stat3. The co-localization with the lyso-
somal membrane was signiﬁcantly reduced, most severely in the case of
cathepsin B, in Stat3 KO mice compared with wild-type.
Conclusions: The strong Stat3-dependent lysosomal membrane localiza-
tion of cathepsin B suggests a role for this proteinase in triggering the
lysosomal membrane permeability associated with the mammary gland
involution.
0988: M1 POLARISED MACROPHAGES DEVELOP AN ENDOTOXIN TOLER-
ANCE-LIKE PHENOMENON IN RESPONSE TO BACTERIAL STIMULATION
N.M. Foley*, J.H. Wang, H.P. Redmond. Cork University Hospital/University
College Cork, Cork, Ireland.
Introduction: To establish a predominant M1and M2 macrophage polar-
isation pattern in vitro. To examine the inﬂammatory cytokine response to
bacterial stimulation in polarised cells. To determine the phagocytic ac-
tivity in polarised cells after bacterial stimulation.
Methods: Peritoneal and bone marrow derived macrophages were har-
vested from C57BL/6 mice. Cells were exposed to polarising stimuli for 18-
24 hours. (M1 - LPS and IFN-g, M2 - IL-4). Polarised cells were further
stimulated with heat-killed Staphylococcus aureus and Salmonella Typhi
or FITC-labeled E coli. Inﬂammatory cytokine production and phagocytosis
were assessed by ELISA and FACScan analysis.
Results: M1 macrophages were characterised by high levels of TNF-a and
IL-12p70 and M2 macrophages by high levels of TGF-b and low levels of
IL12p70. M1 polarized macrophages, when exposed to gram-positive
bacteria, had lower levels of TNF-a than M2 macrophages. Phagocytosis
assays revealed similar results for both macrophage subpopulations.
Conclusions:M1macrophages are expected to produce higher levels of TNF-
a, however we found that M1macrophages, when stimulated with bacteria,
had lower levels of TNF-a compared with their M2 counterparts. This unex-
pected result indicates a tolerisation effect developed during the M1 polar-
isation and further work is required to clarify the underlying mechanism(s).
1094: ASSOCIATION BETWEEN LEVELS OF MATRIX METALLOPROTEI-
NASE-3 AND JOINT REPLACEMENT OF THE HIP AND KNEE IN RHEUMA-
TOID ARTHRITIS
Cara Jenvey 1,*, Samantha Hider 2, John Glossop 1, Jonathan Packham 1,
Peter Dawes 1, Nicola Nixon 1, Derek Mattey 1. 1Haywood Rheumatology
Centre, Haywood Hospital, Stoke-on-Trent, UK; 2Research Institute for
Primary Care and Health Sciences, Keele University, Stoke-on-Trent, UK.
Introduction: Within 20 years 25% of rheumatoid arthritis (RA) patients
will undergo total joint replacement. Matrix metalloproteinase-3 (MMP-3)
is released during the disease process. Previous studies suggest that MMP-
3 levels decrease following joint replacement. The objective of this study
was to investigate if serum levels of MMP-3 at baseline are associated with
future joint replacement of the hip and knee.
Methods: Clinical data and MMP-3 levels were recorded prospectively for
278 RA patients over a 5-year period. The mean (sd) age of the cohort was
59 (9.9) years with a disease duration of 11(9.2) years and 187 (67%) of the
cohort were female.
Results: Signiﬁcantly higher levels of MMP-3 were found at baseline for
those patients who required a joint replacement during the ﬁve year
follow up period (n¼49) than those that did not: median (IQR) MMP-3
level (27,050 (37,146) vs. 19,892 (18,894), p ¼0.005). No signiﬁcant differ-
ence was found between baseline MMP-3 levels and having a joint
replacement prior to the start of the study (n¼32): median (IQR) MMP-3
level (25,705 (21,283) vs. 20,031 (20,258), p ¼0.25).
Conclusions: High levels of MMP-3 are associated with future joint
replacement of the hip or knee in RA patients.
1275: THE EFFECTS OF SOCS7 KNOCKDOWN IN BREAST CANCER CELLS:
THEIR IN VITRO RESPONSE TO HEPATOCYTE GROWTH FACTOR (HGF)
Walid Sasi 1,*, Lin Ye 2, Wen G. Jiang 2, Anup K. Sharma 1, Kefah Mokbel 1.
1 St George's, University of London, London, UK; 2 Cardiff University, Cardiff,
UK.
Introduction: Phospholipase Cg-1 (PLCg-1) is an important Hepatocyte
Growth Factor (HGF) receptor (C-MET) downstream mediator, and recent
evidence showed that Suppressor of Cytokine Signalling 7(SOCS7) - a
member of the SOCS family - interacts with PLCg-1. Here, we aimed to
investigate SOCS7 knockdown effect on breast cancer cellular growth and
migratory responses to HGF treatment, and whether this involves HGF-
PLCg-1 pathway using the PLCg-1 blocker U73122.
Methods: Two breast cancer cell lines (MCF7 and MDA-MB-231) were
transfected with anti-SOCS7 ribozymal transgene, creating sublines
with SOCS7 knockdown (MCF7DSOCS7 and MDA-MB-231DSOCS7), veriﬁed
by RT-PCR. The growth and migration of the cells were evaluated with
and without HGF and U73122 pre-treatment using growth assay,
scratch-wound and Electrical Cell Impedance Sensing (ECIS) migration
assays.
Results: Under basic conditions, both MCF7DSOCS7 and MDA-MB-231DSOCS7
cells showed higher growth and migration compared to control cells.
Additionally SOCS7 knockdown appeared to synergistically enhance their
growth and migratory responses to HGF. U73122 pre-treatment was found
to abrogate this synergistic effect.
Conclusions: HGF pre-treatment and SOCS7 knockdown have a syner-
gistic effect on the growth and migration of MCF7 and MDA-MB-231 cells.
This is lost with pre-treatment with U73122, an alternative PLCg-1 blocker,
indicating a precise anti-PLCg-1 regulatory role for SOCS7.
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0008: USE OF AUTOLOGOUS FAT GRAFTING FOR RECONSTRUCTION
POST-MASTECTOMY AND BREAST CONSERVING SURGERY: A SYSTEM-
ATIC REVIEW AND META-ANALYSIS
Riaz Agha*,1, Alexander Fowler 2, Christian Herlin 3, Tim Goodacre 4,
Dennis Orgill 5. 1Department of Plastic Surgery, Stoke Mandeville Hospital,
UK; 2Barts and the London School of Medicine and Dentistry, QMUL, London,
UK; 3CC-AH en chirurgie plastique, reconstructrice et esthetique, Montpellier,
France; 4Department of Plastic Surgery, John Radcliffe Hospital, Oxford, UK;
5Division of Plastic Surgery, Brigham and Women’s Hospital, Boston,
Massachusetts, USA.
Introduction: There is growing interest in the potential of autologous
fat grafting (AFG) for breast reconstruction. However, concerns
remains regarding its effectiveness, safety and interference with
mammography.
Methods: A protocol was published a priori. All studies investigating AFG
for women undergoing reconstruction post surgery for treatment of breast
cancer were considered. We assessed six domains; Oncological, clinical,
aesthetic/functional, patient reported, process and radiological. Electronic
databases and grey literature sources were searched to June 2013.
Results: 31 studies were included in this review (3,521 patients). Fat ne-
crosis is the commonest reported complication at 4.4% (the majority was
managed conservatively). Other harms include the anxiety caused by the
need for further radiological investigation through interval mammograms
(11.5%) and the need for biopsy (2.5%) to exclude malignancy. The
weighted mean recurrence rate was 4.4% at a median of 18.3 months.
Random effects Meta-analysis showed no signiﬁcant difference (p¼0.10).
We were unable to comment from the data on whether AFG is more
successful in combination with other techniques or alone.
Conclusions: The need for long-term follow up is underscored by this
review. High quality research is required to demonstrate long-term
oncological ramiﬁcations and to determine the potential for AFG as a total
breast reconstruction.
0244: AN EVALUATION OF THE CORRELATION BETWEEN PRIMARY
TUMOUR AND LYMPH NODE RESPONSE FOLLOWING NEOADJUVANT
THERAPY IN BREAST CANCER
C.A. Fleming*, K.N. McCarthy, M.J. O'Sullivan, H.P. Redmond, M.A. Corrigan.
Breast Research Centre, Cork University Hospital, Cork, Ireland.
Introduction: Neoadjuvant therapy (NAT) offers an opportunity to
assess tumour response to systemic agents. However discrepancy may
exist between response of primary tumour & involved nodes. This
study sought to assess the frequency of discordance in this response post
NAT.
Methods: All node positive patients receiving NAT at Cork University
Hospital, Republic of Ireland from 2009-2012 were identiﬁed. Basic
demographics, radiological & pathological features were tabulated &
analysed. Nodal response was estimated from standard pathological
response to treatment measurements. Statistical analysis was performed.
Results: 66 node positive patients had completed surgery & were eligible
for inclusion. Median age was 50 years, all patients underwent axillary
clearance and 64% underwent mastectomy. There was an overall positive
correlation between tumour and lymph node (LN) response following NAT
(Spearman correlation coefﬁcient 0.541, p<0.001). Eleven patients ach-
ieved a LN complete pathological response (CPR) with all having a CPR in
tumour also. A CPR in the tumour predicted complete nodal response in
73% of cases.
Conclusions:While overall correlation was seen, 27% of primary tumours
with CPR had persistently positive LN's. This represents a signiﬁcant
discordance that may be due to biomolecular differences and represents a
concern for the potential lack of response of occult systemic metastasis to
NAT.
0333: BREAST CANCER, WHAT WOULD YOU CHOOSE? e A SURVEY OF
HEALTH PROFESSIONALS
Emma Woolley*,1, Mohammed Elsayed 1, Michael Carr 2,
Ludger Barthelmes 1. 1North Cumbria University Hospitals Trust, Cumbria,
UK; 2Northumbria NHS Trust, Northumbria, UK.
Introduction: To investigate whether medical professionals, when con-
fronted with a breast cancer diagnosis, would ignore evidence-based
medicine in favour of personal preference. Compare the opinion of the
breast team with the actual treatment chosen by their patients.
Methods: Anonymous questionnaire with 3 scenarios given to all (39)
members of the regional MDT and comparison made with patients'
treatment choices.
Results: For a 10 mm, grade 1 cancer 82 % (32/39) of health professionals
favoured WLE over mastectomy, compared to 51 % (31/60) of patients
(p¼0.003). For a 25mm, grade II, invasive cancer 55% (21/38) of medical
professionals favoured WLE compared to 49% (28/57) of patients
(p¼0.67). For 60mm, high grade DCIS, 26% (10/39) of health professionals
would chose mastectomy without reconstruction, compared to 75 % (9/
12) of patients (p¼0.005). Following a mastectomy, 74 % of health pro-
fessionals would have reconstruction: 28 % immediately, 46 % delayed;
whilst of the 25 % of patients with reconstructions all had immediate
reconstruction.
Conclusions: A signiﬁcant majority of health professionals would
choose WLE for grade I and II invasive ductal carcinoma compared to
their patients' treatment choices. For 60mm DCIS, health professionals
were more three times more likely than their patients to choose re-
construction.
0388: THE UTILISATION OF MAGNETIC RESONANCE IMAGING IN THE
INVESTIGATION OF INVASIVE LOBULAR CARCINOMA e A RETROSPEC-
TIVE STUDY IN TWO DISTRICT GENERAL HOSPITALS
Mina Derias*, Ashok Subramanian, Simon Allan, Elizabeth Shah,
Hassan El-Teraiﬁ, David Howlett. East Sussex Healthcare, Eastbourne, UK.
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